Article

Pharmacokinetic /Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19

2021-09-02

Abstract excerpt

Tocilizumab is one of few treatments that have been shown to improve mortality in patients with COVID-19, but increased demand has led to relative global shortages. Recently, it has been suggested that lower doses, or fixed doses, of tocilizumab could be a potential solution to conserve the limited global supply while conferring equivalent therapeutic benefit to the dosing regimens studied in major trials. The rel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b5d1fb0-9a70-5e5a-b2e8-909860229d2a
DOI: 10.1101/2021.08.28.21262692

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacokinetic /Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19DOI 10.1101/2021.08.28.21262692Read

Single Versus Multiple Doses of Tocilizumab in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Two-center, Retrospective Cohort StudySemantic proximity Read

Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and ScotlandSemantic proximity Read

Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trialSemantic proximity Read

Population pharmacokinetics and exposure-response analysis of sotrovimab in the early treatment of COVID-19Semantic proximity Read

Modelling, Extrapolation and Simulation approaches for rare diseases - Review of two case-studies in the INVENTS projectSemantic proximity Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read

Timely Administration of Tocilizumab Improves Survival of Hospitalized COVID-19 PatientsSemantic proximity Read

Making sense of non-randomized comparative treatment studies in times of Covid-19: A case study of tocilizumabSemantic proximity Read

Using Virtual Patients to Evaluate Dosing Strategies for Bispecifics with a Bell-Shaped Efficacy CurveSemantic proximity Read

[Pharmacological and clinical profiles of panitumumab injection (Vectibix®)].Semantic proximity Read

Revisiting acyclovir dosing for viral encephalitis using a Bayesian PBPK modeling approachSemantic proximity Read

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.Semantic proximity Read